Erin Fetsch, PA
Surgical · Mt Pleasant, SCNPI 1841224854
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Peerless Surgical Inc. at 43.7% of the total. Reporting peaked in 2022 at $1,275 and has fallen 51.8% since, to $614 in 2025.
Across 39 payments — averaging $71.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Peerless Surgical Inc.$1K
- Ferring Pharmaceuticals Inc.$692
- Medtronic$168
- Si-bone, Inc.$142
- Akcea Therapeutics, Inc.$125
- Amgen$111
- plus $333 from 7 others
What the payments were for
- Food & beverage$1,59457%
- Education$1,20043%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Peerless Surgical Inc. | 2 | $1,222 |
| Ferring Pharmaceuticals Inc. | 25 | $692 |
| Medtronic | 1 | $168 |
| Si-bone, Inc. | 1 | $142 |
| Akcea Therapeutics, Inc. | 1 | $125 |
| Amgen | 1 | $111 |
| Stryker | 1 | $103 |
| Eisai Inc. | 1 | $86 |
| Bioventus LLC | 1 | $47 |
| Johnson & Johnson | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Abbott | 1 | $18 |
| Smith+Nephew | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYPHON EXPRESS II KYPHOPAK TRAY$168
- TEGSEDI$125
- MAKO$103
How this compares
$2,794 in reported general payments places this provider in the 85th percentile of 232 surgical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 115 | $463 |
| Amoxicillin | 293 | $335 |
| Celecoxib | 35 | $283 |
| Methylprednisolone | 34 | $242 |
| Meloxicam | 48 | $161 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $68 |
| Gabapentin | 21 | $55 |
| Clindamycin Hcl | 43 | $48 |
| Tramadol Hcl | 23 | $22 |
Paid to pharmacies, not to this prescriber.
Other surgical in Mt Pleasant
- John VollmerMt Pleasant$2K
- Olin LonginoMt Pleasant$2K
- Joshua BeardsleyRock Hill$192K
- Carey LennonNorth Charleston$22K
- Bryce StallingsColumbia$16K
- Natalie StapletonGreenville$11K
- Kevin KnappGreenville$11K
- Jeffrey BrownSpartanburg$7K
- Kati CarterGreenville$7K
- Kalley VeitCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.